Cargando…
Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report
Thromboembolism is a known phenomenon in patients with Coronavirus disease 2019 (COVID-19). Recent investigations have revealed that a significant proportion of those hospitalized with severe COVID-19 demonstrate clinical and laboratory markers compatible with hypercoagulability, which is differenti...
Autores principales: | Efendizade, Aslan, Dmytriw, Adam A., Hewitt, Kevin, Davies, Gwynivere A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545009/ https://www.ncbi.nlm.nih.gov/pubmed/33101181 http://dx.doi.org/10.3389/fneur.2020.573356 |
Ejemplares similares
-
Etiologic Subtypes of Ischemic Stroke in SARS-CoV-2 Patients in a Cohort of New York City Hospitals
por: Tiwari, Ambooj, et al.
Publicado: (2020) -
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
por: Pineo, Graham F, et al.
Publicado: (2012) -
Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014) -
Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin
por: Workman, Wesley E., et al.
Publicado: (2020) -
Safety and Efficacy of Heparinization During Mechanical Thrombectomy in Acute Ischemic Stroke
por: Yang, Ming, et al.
Publicado: (2019)